2
0

To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.

6/27/2025, 8:06 AM

Summary of Bill HR 4191

H.R. 4191 introduced in the 119th Congress on June 26, 2025, aims to enhance the coordination of Federal activities related to recognizing and minimizing health and national security threats by establishing a registry of crucial medicines, executing risk evaluations of these medicines' supply chains, and establishing a monitoring apparatus to outline these supply chains through data analysis.

Current Status of Bill HR 4191

Bill HR 4191 is currently in the status of Bill Introduced since June 26, 2025. Bill HR 4191 was introduced during Congress 119 and was introduced to the House on June 26, 2025.  Bill HR 4191's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 26, 2025

Bipartisan Support of Bill HR 4191

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 4191

Primary Policy Focus

Alternate Title(s) of Bill HR 4191

To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.
To improve coordination of Federal efforts to identify and mitigate health and national security risks through maintaining a list of essential medicines, conducting a risk assessment of essential medicine supply chains, and creating a monitoring system to map essential medicine supply chains using data analytics.

Comments